Kai Liang
- Topics
- Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers)Metabolism, Diabetes, and Cancer (8 papers)Liver Disease Diagnosis and Treatment (6 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Kai Liang
31 papers receiving 439 citations
Peers
Comparison fields: 5 of 81
- Endocrinology, Diabetes and Metabolism 134
- Molecular Biology 132
- Epidemiology 120
- Surgery 114
- Physiology 70
Countries citing papers authored by Kai Liang
This map shows the geographic impact of Kai Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Liang more than expected).
Fields of papers citing papers by Kai Liang
This network shows the impact of papers produced by Kai Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Liang. The network helps show where Kai Liang may publish in the future.
Co-authorship network of co-authors of Kai Liang
This figure shows the co-authorship network connecting the top 25 collaborators of Kai Liang. A scholar is included among the top collaborators of Kai Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Liang. Kai Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 1 | |
| 4 | 36 | |
| 5 | 9 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 39 | |
| 9 | 2 | |
| 10 | 6 | |
| 11 | 12 | |
| 12 | 14 | |
| 13 | 10 | |
| 14 | 21 | |
| 15 | 16 | |
| 16 | 22 | |
| 17 | 1 | |
| 18 | 1 | |
| 19 | 22 | |
| 20 | 41 |
About Kai Liang
Kai Liang is a scholar working on Endocrinology, Diabetes and Metabolism, Aging and Geriatrics and Gerontology, having authored 32 papers that have together received 446 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Metabolism, Diabetes, and Cancer (8 papers) and Liver Disease Diagnosis and Treatment (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (134 citations), Epidemiology (120 citations) and Nephrology (22 citations). Kai Liang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xinguo Hou, Li Chen, Lingshu Wang, Fei Yan, Tianyi He, Ruxing Zhao, Fuqiang Liu, Xinghong Guo, Fuqiang Liu and Yingchun Wang. Their work appears in journals such as Nature Communications, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.